B

BML Capital Management, LLC Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for BML Capital Management, LLC with $110.6M in long positions as of Q3 2025, 89% allocated to Healthcare, and 93% concentrated in top 10 positions.

Portfolio Value
$110.6M
Top 10 Concentration
93%
Top Sector
Healthcare (89%)
US Exposure
97%
Market Cap Focus
Micro Cap
Countries
3

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 89.00%HealthcareIndustrials: 1.00%Consumer Defensive: 0.80%
Healthcare
89.00%
Industrials
1.00%
Consumer Defensive
0.80%

Industry Breakdown

4 industries across all sectors

Biotechnology: 64.56%BiotechnologyMedical - Diagnostics & Research: 24.48%Medical - Diagnostics & ResearchAerospace & Defense: 0.98%Discount Stores: 0.81%
Biotechnology
Healthcare
64.56%
Medical - Diagnostics & Research
Healthcare
24.48%
Aerospace & Defense
Industrials
0.98%
Discount Stores
Consumer Defensive
0.81%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Large Cap ($10B - $200B): 0.81%Small Cap ($300M - $2B): 4.75%Micro Cap ($50M - $300M): 86.56%Micro Cap ($50M - $300M)Nano Cap (< $50M): 7.87%
Large Cap ($10B - $200B)
0.81%
Small Cap ($300M - $2B)
4.75%
Micro Cap ($50M - $300M)
86.56%
Nano Cap (< $50M)
7.87%

Portfolio Concentration

Top 10 Holdings %
92.69%
Top 20 Holdings %
100.0%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
97.11%
International
2.89%
Countries
3
Largest Int'l Market
Netherlands - 2.78%
United States of America
97.11% ($107.4M)
17 holdings
Netherlands
2.78% ($3.1M)
1 holdings
Ireland
0.11% ($119.0K)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
6.3 quarters
Avg. Top 20
5.9 quarters
Avg. All Positions
5.9 quarters
Median Holding Period
7 quarters
Persistence Rate
63.16%
Persistent Holdings Weight
87.66%
Persistent Positions
12
Longest Held
Lisata Therapeutics, Inc. Common Stock logo
Lisata Therapeutics, Inc. Common StockLSTA - 11 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
0.43%
Avg. Position Weight
5.26%
Largest Position
Aclaris Therapeutics, Inc. logo
Aclaris Therapeutics, Inc.ACRS - 24.48%
Largest Ownership Stake
Adverum Biotechnologies, Inc. Common Stock logo
Adverum Biotechnologies, Inc. Common StockADVM - 14.57%
Avg. Ownership Stake
9.94%
Ownership Stake >5%
10
Ownership Stake >1%
14

Historical (Since Q4 2022)

Avg. New Position
2.84%
Avg. Ownership Stake
6.78%
Largest Position
iShares 0-3 Month Treasury Bond ETF logo
iShares 0-3 Month Treasury Bond ETFSGOV - 28.46% (Q3 2023)
Largest Ownership Stake
Aclaris Therapeutics, Inc. logo
Aclaris Therapeutics, Inc.ACRS - 19.97% (Q3 2024)

Portfolio Turnover

Current Quarter

Turnover Ratio
9.4%
Value Traded
$10.44M
Positions Added
3
Positions Exited
7

Historical (Since Q4 2022)

Avg. Turnover Ratio
23.2%
Avg. Positions Added
7
Avg. Positions Exited
6
Highest Turnover
50.0%
Q4 2022
Lowest Turnover
9.4%
Q3 2025

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.